Monday, July 21, 2014

Q3 Media Relations Efforts Drive Q1 Results

by David D. Menzies   
It might seem strange to be in the midst of the dog days of summer talking about landing coverage in target media outlets in January, February, and March of next year, but the truth of the matter is now is the time to ramp-up PR and media relations efforts to achieve the greatest success. As I am fond of saying in articles and presentations, public relations is not brain surgery, BUT it does take planning in order to achieve the greatest return on investment. Unfortunately, a lot of times business executives without experience utilizing PR think of it as a push-button type of tool like advertising, wherein you simply buy ad space, slap an ad together and get it published. Like most things in life, the easiest efforts don't always achieve the greatest results. If you're serious about securing meaningful editorial coverage for your business, product, or service in trusted third-party media outlets your prospects and customers rely on for news and information, it will take a little more effort but the payoff will be much more significant.

Monday, July 14, 2014

Happy Fix® Celebrating What’s Great with HPY Directory

THE PEAK OF GOOD LIVING: APEX, N.C.  -- North Carolina’s happiest startup, Happy Fix® (, recently launched its HPY Directory, a collection of user-submitted lists of places and things that help people celebrate what’s great in life. In return, Happbassadors (happiness ambassadors) who send in their lists will receive special discount codes for purchases of official Happy Fix apparel and accessories featuring the company’s popular HPY logo design, which serves as a constant reminder for people that happiness is a choice that is always within reach.

lettrs Announces Release of New Android App

NEW YORK, N.Y. -- Mobile technology platform lettrs™, today announced the launch of its new native Android mobile and tablet application. The free Android app is an extension of its popular iPhone app, the first messaging platform to power, publish and deliver personal letters that are distributed across the lettrs network, social networks, and even a physical mail option. A personal letter can now be composed on a Kindle, signed, and experienced on a Google Nexus, then stored in a cloud based shoebox for generations.

Thursday, July 10, 2014

Micro-Combined Heat and Power Steam Engines Are Next Wave in Energy Production

NORWAY -- A cheaper and cleaner energy source is something every homeowner and business owner desires, and Norwegian startup GasDecEngine Technology AS (GDE) has developed a product to meet the demand. GDE’s micro-combined heat and power (micro CHP) steam engines provide efficient energy on location with fewer emissions. GDE has launched a crowdfunding campaign to raise $150,000 by August 3 to combine with a $180,000 government grant to build a market prototype.

Wednesday, July 9, 2014

Compugen Discloses Achievement of Milestone in Cancer Immunotherapy Collaboration with Bayer

TEL AVIV, ISRAEL -- Compugen Ltd. (NASDAQ: CGEN) disclosed today that it has achieved the initial milestone in the cancer immunotherapy collaboration it entered last year with Bayer HealthCare (Bayer). The collaboration provides for the development and commercialization of therapeutic antibodies against two checkpoint protein candidates discovered by Compugen. The milestone being announced today relates to the first preclinical milestone for one of two checkpoint protein candidates for which Compugen will receive a $1.2 million payment out of the $30 million potential milestone payments associated with joint preclinical research for the two programs.

Orgenesis Signs Agreement with MaSTherCell to Scale Manufacturing of Insulin-Producing Liver Cells to Combat Diabetes

WHITE PLAINS, N.Y. -- Orgenesis Inc. (OTCQB:ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine today announced that its Belgian subsidiary, Orgenesis SPRL, has signed a strategic agreement with MaSTherCell SA of Gosselies, Belgium. Orgenesis believes that the agreement will enable Orgenesis to advance its manufacturing (GMP) process from lab scale to clinical scale as it prepares for Phase I and Phase II clinical trials.

BIRD – Israel-U.S. Binational Industrial R&D Foundation to Invest $9 Million in New Projects

WASHINGTON, D.C. -- During its meeting on June 26, 2014, held in Washington D.C., the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation, approved $8.9 million in funding for eleven new projects between Israeli and American companies. In addition to the grants from BIRD, the projects will access private sector funding, boosting the total value of all projects to approximately $25 million.